Helicobacter pylori - More light, less heat

American Journal of Gastroenterology

Volumn 93, Issue 3, 1998, Pages 306-310

  Moss, S F ^b   Fendrick, A M ^b   Cave, D R ^b   Modlin, I M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; CANCER PREVENTION; GASTRITIS; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH CANCER; STOMACH MUCOSA; STOMACH ULCER; TREATMENT INDICATION;

DISEASE MODELS, ANIMAL; GASTRIC ACID; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0032033971     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00007-0     Document Type: Review

References (40)

1. 1. Neale KR, Logan RPH. The epidemiology and transmission of Helicobacter pylori infection in childhood. Aliment Pharmacol Ther 1995; 9(suppl 2):77-84.
2. 2. Goodman KJ, Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol 1995;143:875-87.
3. 3. Thomas JE, Gibson GR, Darboe MK, et al. Isolation of Helicobacter pylori from human faeces. Lancet 1992;340:1194-5.
4. 4. Megraud F. Transmission of Helicobacter pylori: Fecal-oral versus oral-oral route. Aliment Pharmacol Ther 1995;9(suppl 2):85-9.
5. 5. Hulten K, Enroth H, Nystrom T, Engstrand L. Helicobacter pylori is detected by PCR and hybridization in water from Sweden. Gut 1996; 39(suppl 2):A87-8.
6. 6. Tytgat GN. Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther 1995;9(suppl 2):105-10.
7. 7. Eaton KA, Radin MJ, Krakowka S. An animal model of gastric ulcer due to bacterial gastritis in mice. Vet Pathol 1995;32:489-97.
8. 8. Krakowka S, Eaton KA, Rings DM. Occurrence of gastric ulcers in gnotobiotic piglets colonized by Helicobacter pylori. Infect Immun 1995;63:2352-5.
9. 9. Mohammedi M, Redline R, Nedrud J, et al. Role of the host in the pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996;64:238-45.
10. 10. Tomb J-F, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388:539-47.
11. 11. Phadnis SH, Parlow MH, Levy M, et al. Surface localization of Helicobacter pylori and a heat shock protein homolog requires bacterial autolysis. Infect Immun 1996;64:905-12.
12. 12. Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut 1997;40:701-3.
13. 13. Peek RM, Thompson SA, Atherton JC, et al. Expression of a novel ulcer-associated H. pylori gene, iceA, following adherence to gastric epithelial cells. Gastroenterology 1996;110:A225.
14. 14. Calam J. The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med 1995;27:569-73.
15. 15. Kidd M, Miu K, Tang LH, et al. H. pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat ECL cells. Gastroenterology 1997;113:1110-7.
16. 16. McGowan CC, Cover TL, Blaser MJ. Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology 1996; 110:926-38.
17. 17. Huang LL, Cave DR, Wright A. Sequencing and expression of the gene encoding a novel protein with gastric acid inhibitory properties from Helicobacter pylori. Gut 1996:39(suppl 2):A66.
18. 18. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996;110:725-32.
19. 19. Sachs G. Gastritis, Helicobacter pylori and proton pump inhibitors. Gastroenterology 1997;112:1033-6.
20. 20. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334: 1018-22.
21. 21. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, et al. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Castro 1997;(suppl 223):28-34.
22. 22. Dixon MF, Genta R, Yardley JH, et al. Classification and grading of gastritis: The upgraded Sydney system. Am J Surg Pathol 1996;20: 1161-81.
23. 23. Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996;38:498-501.
24. 24. Eissele R, Brunner G, Simon B, et al. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997;112:707-17.
25. 25. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
26. 26. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-83.
27. 27. Axon A, Forman D. Helicobacter gastroduodenitis: A serious infectious disease. Br Med J 1997;314:1430-1.
28. 28. Peura DA. The report of the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology 1997; 113:54-8.
29. 29. Blaser MJ. Not all Helicobacter pylori strains are created equal: Should all be eliminated? Lancet 1997;349:1020-2.
30. 30. Werdmuller BFM, Loffeld RJLF. H. pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997;42:103-5.
31. 31. Labenz J, Blum A, Bayerdörffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
32. 32. Taha AS, Reid J, Boothman P, et al. Serological diagnosis of Helicobacter pylori - evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993;34:461-5.
33. 33. Chan FKL, Sung JY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroiclal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997;350:975-9.
34. 34. European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997;41:8-13.
35. 35. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomakers Prev 1997;6:639-42.
36. 36. Graham DY, Rabeneck L. Patients, payers, and paradigm shifts: What to do about Helicobacter pylori. Am J Gastroenterol 1996;91:188-90.
37. 37. Ofman JJ, Etchason J, Fullerton S, et al. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: Clinical and economic consequences. Ann Intern Med 1997;126:282-91.
38. 38. Harris AW, Gummett PA, Phull PS, et al. Recurrence of duodenal ulcers after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol Ther 1997;11:331-4.
39. 39. Forbes GM, Glaser ME, Cullen DJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up. Lancet 1994; 343:258-60.
40. 40. Parsonnet J, Harris RA, Hack HM, et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996;348:150-4.